Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: A Multicenter, randomized, placebo-controlled trial

Journal of Investigative Dermatology

Volumn 130, Issue 8, 2010, Pages 2041-2048

  Beissert, Stefan ^a   Mimouni, Daniel ^b,c   Kanwar, Amrinder J ^d   Solomons, Neil ^e   Kalia, Veena ^e   Anhalt, Grant J ^f  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^e Vifor (International) Inc   (Switzerland)

^f JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE;

ACNE; ADULT; ARTHRALGIA; ARTICLE; BONE NECROSIS; CATARACT; CEREBROVASCULAR ACCIDENT; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DUODENUM ULCER; FEMALE; FEVER; FOOD POISONING; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTPATIENT; PANCREATITIS; PEMPHIGUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; THRUSH; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; ADULT; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; OUTPATIENTS; PEMPHIGUS; PLACEBOS; PREDNISONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77954759254     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.91     Document Type: Article

References (25)

1. Abasq C, Mouquet H, Gilbert D et al. (2009) ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. Arch Dermatol 145:529-535
2. Amagai M, Ikeda S, Shimizu H, et al. (2009) A randomized double-blind trial of intravenous immunoglobulin for pemphigus. J Am Acad Dermatol 60:595-603
3. Amagai M, Klaus-Kovtun V, Stanley JR (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-877
4. Baskan EB, Yilmaz M, Tunali S et al. (2009) Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris. J Eur Acad Dermatol Venereol 23:1432-1434
5. Beissert S, Werfel T, Frieling U et al. (2006) A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 142:1447-1454
6. Bystryn JC, Steinman NM (1996) The adjuvant therapy of pemphigus. An update. Arch Dermatol 132:203-212
7. Carson PJ, Hameed A, Ahmed AR (1996) Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 34:645-652
8. Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. (2007) Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. JAm Acad Dermatol 57:622-628
9. Chams-Davatchi C, Nonahal Azar R, Daneshpazooh M et al. (2002) [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris]. Ann Dermatol Venereol 129:23-25
10. Enk AH, Knop J (1997) Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 350:494
11. Enk AH, Knop J (1999) Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 135:54-56
12. Esmaili N, Chams-Davatchi C, Valikhani M et al. (2008) Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent. Eur J Dermatol 18:159-164
13. Ho VC, Zloty DM (1993) Immunosuppressive agents in dermatology. Dermatol Clin 11:73-85
14. Joly P, Mouquet H, Roujeau JC, et al. (2007) A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med 357:545-552
15. Martin LK, Agero AL, Werth V et al. (2009) Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev, CD006263
16. Mimouni D, Anhalt GJ, Cummins DL et al. (2003) Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol 139:739-742 (Pubitemid 36705940)
17. Mukhtar O, Jones K (2003) Trauma surgery: burns. Student BMJ 11:230-231
18. Nousari HC, Sragovich A, Kimyai-Asadi A et al. (1999) Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol 40:265-268
19. Robinson JC, Lozada-Nur F, Frieden I (1997) Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 84:349-355
20. Saha M, Black MM, Groves RW (2008) Risk of herpes zoster infection in patients with pemphigus on mycophenolate mofetil. Br J Dermatol159:1212-1213
21. Stanley JR (1999) Therapy of pemphigus vulgaris. Arch Dermatol 135: 76-78
22. Toth GG, Jonkman MF (2001) Therapy of pemphigus. Clin Dermatol 19:761-767
23. Ware Jr JE, Kosinski M, Gandek B (2000) SF-36 Health Survey: Manual & Interpretation Guide. QualityMetric: Lincoln, RI
24. Yeh SW, Sami N, Ahmed RA (2005) Treatment of pemphigus vulgaris. Current and emerging options. Am JClin Dermatol 6:327-42
25. Zwerner J, Fiorentino D (2007) Mycophenolate mofetil. Dermatol Ther 20:229-238